FindTrial
Sign In

A nationwide retrospective study of malignant tumors arising from ovarian mature teratoma in Japan

A nationwide retrospective study of malignant tumors arising from ovarian mature teratoma in Japan - JGOG3034

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000054168
Enrollment
200
Registered
2024-04-20
Start date
2024-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumors arising from ovarian mature teratoma

Interventions

None listed

Sponsors

Japanese Gynecologic Oncology Group
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Cases with a confirmed histological diagnosis of malignancy arising from ovarian mature teratoma during the 10-year period from July 2013 to June 2023.

Exclusion criteria

Exclusion criteria: The individual or family member has clearly expressed a refusal to opt out. The researcher considers it inappropriate, citing difficulties in obtaining data.

Design outcomes

Primary

MeasureTime frame
No key outcomes will be established.—

Countries

Japan

Contacts

Public ContactRyo Tamura

Niigata University Department of Obstetrics and Gynecology

ryo-h19@med.niigata-u.ac.jp025-227-2320

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026